Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 86 |
| Active Pipeline (Recruiting Now) | 48 (28) |
| Completed vs Stopped Early | 27 / 10 (11.6%) |
| Median Closed Actual Enrollment | 23 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| UC San Diego Health and Moores Cancer Center | San Diego, CA | 70 |
| Rady Children's Hospital - San Diego | San Diego, CA | 3 |
| UCSF Medical Center and Helen Diller Cancer Center | San Francisco, CA | 2 |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for UC San Diego Health across sibling Meru public-data platforms.
Explore interactive annual charts and M&A subsidiary rollups in the UC San Diego Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.